EICHOR
● Active Not Recruiting
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Condition: Solid Tumors · Neuroblastoma · Rhabdomyosarcoma · Sponsor: Valent Technologies, LLC
About this study
A pilot pharmacokinetic trial to determine the safety and efficacy of a flavored, orally administered irinotecan VAL-413 (Orotecan®) given with temozolomide for treatment of recurrent pediatric solid tumors including but not limited to neuroblastoma, rhabdomyosarcoma, Ewing sarcoma, hepatoblastoma and medulloblastoma
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (11)
| Phoenix Children's Hospital | Phoenix, Arizona, United States | — |
| UCSF, Mission Bay - Benioff Children's Hospital | San Francisco, California, United States | — |
| Children's National Research Institute - Children's National Hospital | Washington D.C., District of Columbia, United States | — |
| Children's Healthcare of Atlanta - Arthur M. Blank Hospital | Atlanta, Georgia, United States | — |
| Indiana University School of Medicine, Riley Hospital for Children | Indianapolis, Indiana, United States | — |
| Washington University - St. Louis | St Louis, Missouri, United States | — |
| University of North Carolina at Chapel Hill - North Carolina Cancer Hospital | Chapel Hill, North Carolina, United States | — |
| Atrium Health Levine Children's Hospital - Carolinas Medical Center | Charlotte, North Carolina, United States | — |
| Duke University Children's Hospital and Health Center | Durham, North Carolina, United States | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | — |
| Sarah Cannon Research Institute, Pediatric Hematology & Oncology | Nashville, Tennessee, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.